| Sensing and modulation of invadopodia across a wide range of rigidities A Parekh, NS Ruppender, KM Branch, MK Sewell-Loftin, J Lin, PD Boyer, ... Biophysical journal 100 (3), 573-582, 2011 | 140 | 2011 |
| Cadherin-11 regulates cell–cell tension necessary for calcific nodule formation by valvular myofibroblasts JD Hutcheson, J Chen, MK Sewell-Loftin, LM Ryzhova, CI Fisher, YR Su, ... Arteriosclerosis, thrombosis, and vascular biology 33 (1), 114-120, 2013 | 122 | 2013 |
| Cancer-associated fibroblasts support vascular growth through mechanical force MK Sewell-Loftin, SVH Bayer, E Crist, T Hughes, SM Joison, ... Scientific reports 7 (1), 12574, 2017 | 116 | 2017 |
| EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology MK Sewell-Loftin, YW Chun, A Khademhosseini, WD Merryman Journal of cardiovascular translational research 4, 658-671, 2011 | 85 | 2011 |
| Notch1 Mutation Leads to Valvular Calcification Through Enhanced Myofibroblast Mechanotransduction J Chen, LM Ryzhova, MK Sewell-Loftin, CB Brown, SS Huppert, ... Arteriosclerosis, thrombosis, and vascular biology 35 (7), 1597-1605, 2015 | 67 | 2015 |
| Novel technique for quantifying mouse heart valve leaflet stiffness with atomic force microscopy MK Sewell-Loftin, CB Brown, HS Baldwin, WD Merryman The Journal of heart valve disease 21 (4), 513, 2012 | 57 | 2012 |
| Mechanoregulation of vascular endothelial growth factor receptor 2 in angiogenesis B Miller, MK Sewell-Loftin Frontiers in Cardiovascular Medicine 8, 804934, 2022 | 28 | 2022 |
| Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cells MK Sewell-Loftin, DM DeLaughter, JR Peacock, CB Brown, HS Baldwin, ... Biomaterials 35 (9), 2809-2815, 2014 | 28 | 2014 |
| Micro-strains in the extracellular matrix induce angiogenesis MK Sewell-Loftin, JB Katz, SC George, GD Longmore Lab on a Chip 20 (15), 2776-2787, 2020 | 22 | 2020 |
| Proteomic Alterations Associated with Biomechanical Dysfunction are Early Processes in the Emilin1 Deficient Mouse Model of Aortic Valve Disease PM Angel, DA Narmoneva, MK Sewell-Loftin, C Munjal, L Dupuis, ... Annals of biomedical engineering 45, 2548-2562, 2017 | 17 | 2017 |
| Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment M Monavarian, AT Elhaw, PW Tang, Z Javed, Z Shonibare, CB Scalise, ... Seminars in Cancer Biology 86, 709-719, 2022 | 12 | 2022 |
| Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling X Qu, K Violette, MK Sewell-Loftin, J Soslow, LS Saint-Jean, RB Hinton, ... Developmental biology 455 (1), 73-84, 2019 | 11 | 2019 |
| Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis VS Shirure, MK Sewell-Loftin, SF Lam, TD Todd, PY Hwang, SC George Tumor Organoids, 117-148, 2018 | 3 | 2018 |
| Protocol for indirect and direct co-culture between human cancer cells and endothelial cells Y Guo, B Miller, M Heim, A Gutierrez-Garcia, R Jaskula-Sztul, B Ren, ... STAR Protocols 4 (2), 102177, 2023 | 2 | 2023 |
| The Role of SRC in Strain-and Ligand-Dependent Phenotypic Modulation of Mouse Embryonic Fibroblasts MK Sewell-Loftin, WD Merryman Summer Bioengineering Conference 54587, 337-338, 2011 | 2 | 2011 |
| Mechanical activation and expression of HSP27 in epithelial ovarian cancer M Buckley, M Kramer, B Johnson, G Huskin, J Berry, MK Sewell-Loftin Scientific Reports 14 (1), 2856, 2024 | 1 | 2024 |
| Biomechanical stimulation promotes blood vessel growth despite VEGFR-2 inhibition BM Johnson, AMK Johnson, M Heim, M Buckley, B Mortimer, JL Berry, ... BMC biology 21 (1), 290, 2023 | 1 | 2023 |
| Biomaterial Considerations for Ovarian Cancer Models M Kramer, A Criswell, MK Sewell-Loftin Frontiers in Materials 10, 1223276, 2023 | 1 | 2023 |
| Abstract B063: Vascular senescence associated cell migration inducing hyaluronidase-1 production promotes ovarian cancer migration and tumorigenesis A Kumari, P Clark, M Monavarian, LQ Macias, R Arend, C Margaroli, ... Cancer Research 84 (5_Supplement_2), B063-B063, 2024 | | 2024 |
| Characterizing differential efficacy and phenotypic response to proteasome and survivin inhibitors in colorectal cancers using a high throughput organoid assay. D Zuaiter, P Ahirwar, AG Pokal, ZH Patel, AA Charania, CL Crawford, ... Journal of Clinical Oncology 42 (3_suppl), 153-153, 2024 | | 2024 |
W. David MerrymanWalters Family Professor, Biomedical Engineering, Vanderbilt UniversityVerified email at vanderbilt.edu
